Question 1

What is Reclast?

Accepted Answer

Reclast is a type of medication known as a bisphosphonate. It works by slowing the natural process that breaks down bone tissue in the body.

By reducing the rate of bone loss, this medication helps to maintain bone density and improve bone strength. This process is intended to help protect the skeletal structure and reduce the risk of bone-related injuries.

Question 2

What is Reclast used for?

Accepted Answer

Reclast is used to treat:

osteoporosis

glucocorticoid-induced osteoporosis

Paget's disease of bone

Question 3

How does Reclast work?

Accepted Answer

Bone Remodeling

Bone is a living tissue that is constantly changing. Throughout life, the body performs a process called remodeling, where old bone is broken down and replaced with new bone. In healthy adults, the rate of bone breakdown and bone formation is usually balanced.

Slowing Bone Loss

In conditions like osteoporosis or Paget's disease, the cells that break down bone, called osteoclasts, become more active than the cells that build it. This leads to a loss of bone density, making bones weaker and more likely to break. Reclast works by targeting this process in the following ways:

Inhibiting osteoclasts: The medication binds to the mineral surface of the bone. When osteoclasts attempt to break down the bone tissue, they absorb the medication, which slows their activity and reduces bone resorption.

Increasing bone mass: By reducing the rate at which bone is lost, the body is better able to maintain or increase bone mineral density over time.

Reducing fracture risk: Strengthening the internal structure of the bone helps prevent fractures in the hip, spine, and other vulnerable areas.

Because the medication binds directly to the bone mineral, its effects can last for a long period. This long-lasting action is why the medication is typically administered as an intravenous infusion only once a year or once every two years, depending on the specific condition being treated.

Question 4

What are the active ingredients in Reclast?

Accepted Answer

The active ingredient in Reclast is zoledronic acid .

Question 5

What are the side effects of Reclast?

Accepted Answer

Common side effects of Reclast may include:

flu-like symptoms

fever

muscle pain

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Reclast?

Accepted Answer

Reclast belongs to the bisphosphonate drug class.

Question 7

What is the dosage of Reclast and how do I take it?

Accepted Answer

Administration

Reclast is given as an injection into a vein by a healthcare provider in a clinical setting, such as a doctor's office or hospital. The infusion process generally takes a short period of time to complete.

Frequency

The timing of doses depends on the specific reason for treatment. For many patients, the medication is given once a year or once every two years. For certain conditions, such as Paget's disease, a single dose may be sufficient.

Hydration and Preparation

It is important to be well-hydrated before and after receiving the infusion. Patients are typically advised to drink plenty of fluids, such as water, shortly before the appointment. Maintaining hydration helps protect the kidneys during treatment.

Missed Dose

If an appointment for a scheduled infusion is missed, contact your healthcare provider as soon as possible to reschedule the treatment.

Supplements

To ensure the medication works effectively and to maintain healthy calcium levels, healthcare providers often recommend taking daily calcium and vitamin D supplements. It is important to follow the specific supplement regimen prescribed by your doctor.

Question 8

Is Reclast safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Reclast may cause harm to an unborn baby and is generally not recommended for use during pregnancy. It is important to notify a healthcare provider if you are pregnant or planning to become pregnant before starting treatment.

Because Reclast stays in the bone matrix for a long period of time, there is a theoretical risk that the drug could affect a fetus even if pregnancy occurs years after the last dose. The impact of this long-term exposure on fetal development is not yet fully understood.

Breastfeeding

It is currently unknown if Reclast passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers usually recommend caution. Patients should consult with their doctor to weigh the risks and benefits of breastfeeding while using this medication.

Question 9

What forms and strengths does Reclast come in?

Accepted Answer

Available Forms

Reclast is provided as a sterile solution for administration into a vein. It is available in the following form:

Intravenous Infusion: A liquid solution supplied in a bottle for administration through a needle or catheter.

This medication is administered by a healthcare provider, typically in a doctor's office or infusion center. It is not available in oral forms such as tablets or capsules.

Question 10

What is the FDA approval status of Reclast?

Accepted Answer

FDA Approval and Indications

Reclast is FDA-approved for the treatment and prevention of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It is also indicated for the treatment and prevention of glucocorticoid-induced osteoporosis and for the treatment of Paget's disease of the bone.

Safety Communications

The FDA has issued safety communications regarding the risk of kidney failure associated with Reclast. In 2011, the drug label was updated to include a contraindication for patients with severe kidney impairment (creatinine clearance less than 35 mL/min) or acute kidney failure. Healthcare providers are required to screen patients' serum creatinine levels before each dose to monitor kidney function.

Regulatory Warnings

The FDA monitors several serious but rare risks associated with bisphosphonates like Reclast, including:

Osteonecrosis of the jaw: This condition involves the death of jawbone tissue and is often linked to invasive dental work.

Atypical femur fractures: These are unusual fractures of the thigh bone that can occur even with minimal trauma.

Severe musculoskeletal pain: Some patients may experience debilitating bone, joint, or muscle pain after starting treatment.

Question 11

What should I know about Reclast and infusion?

Accepted Answer

Administration Process

Reclast is delivered directly into a vein through an intravenous (IV) line. The infusion process must last at least 15 minutes to ensure the medication is delivered safely. It is administered by a doctor or nurse in a clinical setting, such as a hospital or infusion center.

Preparation and Hydration

Proper hydration is essential before and after receiving the infusion. Patients are generally advised to:

Drink at least two glasses of water (about 2 cups) shortly before the infusion.

Continue drinking plenty of fluids for the remainder of the day after the procedure.

Infusion Schedule

The frequency of Reclast infusions depends on the medical reason for the treatment:

Osteoporosis treatment: Usually given once every year.

Osteoporosis prevention: Usually given once every two years.

Paget's disease: Often administered as a single dose, though additional doses may be needed if the condition recurs.

Post-Infusion Reactions

It is common to experience flu-like symptoms after the first infusion, such as fever, chills, muscle aches, or joint pain. These symptoms typically begin within three days of the infusion and usually resolve within three days. Taking acetaminophen shortly after the infusion may help reduce these side effects.

Reclast

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Infusion Information

FAQ

Additional Resources

Support & Help Resources

📚References

Found an Error?

Reclast Price Comparison & Savings Options

Not Medical Advice

Hospitals.net Disclosure